학술논문
Patient Reported Outcomes in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10976787